Atrial Fibrillation Trial, Recruiting NCT05411614 Sponsor: St. George's Hospital, London Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05411614
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have a type of irregular heartbeat called atrial fibrillation (AF) that is either persistent (lasting a long time without stopping on its own) or long-standing persistent (lasting more than a year)
  • People whose left atrium (one of the heart's upper chambers) is at least moderately enlarged
  • People whose heart is pumping with less than 50% of its normal efficiency (a measurement called the ejection fraction)
  • People who are medically suitable for either of the procedures being studied in the trial

Who may not be able to join:

  • People whose AF or heart failure has not yet been fully managed through available medications or lifestyle changes
  • People who are unable to provide written consent to participate
  • People who have had open-heart surgery in the past
  • People with an active infection, or certain conditions affecting the food pipe (oesophagus), such as ulcers, narrowing, or enlarged veins
  • People who have previously had a catheter ablation procedure specifically for atrial fibrillation (prior ablation for other heart rhythm conditions may still be acceptable — confirm with trial site)
  • People who cannot take blood-thinning medications, or who have a blood clot in the left atrium that has not resolved despite blood-thinning treatment
  • People with severe disease affecting the heart valves
  • People with unstable coronary artery disease (a condition affecting the blood supply to the heart)
  • People with an uncontrolled irregular heart rhythm originating from the lower chambers of the heart
  • People who have had a heart attack or stroke within the past 90 days
  • People who are pregnant, breastfeeding, or women of childbearing age who plan to become pregnant within six months
  • People with a serious existing medical condition, or an implanted medical device, that would prevent participation in the trial procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Riyaz A Kaba, St Georges Hospital NHS Trust

Phone: 020 8725 4571

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
St. George's Hospital, London
Registry
ClinicalTrials.gov
Start date
25 June 2022
Est. completion
1 May 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Freedom from persistent atrial arrhythmia after a single procedure (either the completed hybrid ablation or catheter ablation) off Class I or III medications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov